Earnings calendar/PTCT
PTC Therapeutics, Inc. (PTCT)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 3, 2026
Consensus estimate row
EPS target
$0.15
Street estimate
Revenue target
$302.3M
Street estimate
Trailing EPS (avg 4Q)
$-0.14
Beat rate last 4: 75%
Latest EPS YoY
+210.8%
vs 2025-08-07
Latest revenue YoY
+101.5%
How results look so far
Trailing revenue (avg 4Q)
$252.2M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Jul 30, 2026
EPS beat
EPS actual / est
$0.92 / $0.24
+289.3%
Revenue actual / est
$360.5M / $298.6M
+20.7%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/3/2026upcoming | $0.15 | Pending | — | $302.3M | Pending | — |
| 7/30/2026 | $0.24 | $0.92 | +289.3% | $298.6M | $360.5M | +20.7% |
| 5/7/2026 | $-0.45 | $-0.03 | +93.3% | $217.4M | $272.6M | +25.4% |
| 5/5/2026upcoming | $-0.47 | Pending | — | $219.6M | Pending | — |
| 2/26/2026upcoming | $-0.95 | Pending | — | — | Pending | — |
| 2/19/2026 | $-0.21 | $-1.67 | -695.2% | $279.5M | $164.7M | -41.1% |
| 11/4/2025 | $-1.19 | $0.20 | +116.8% | $281.5M | $211.0M | -25.0% |
| 8/7/2025 | $-1.07 | $-0.83 | +22.4% | $191.5M | $178.9M | -6.6% |
| 5/6/2025 | $-1.08 | $10.04 | +1029.6% | $372.6M | $1.18B | +215.6% |
| 2/27/2025 | $-1.12 | $-0.24 | +78.6% | $249.0M | $213.2M | -14.4% |
| 11/7/2024 | $-1.54 | $-1.39 | +9.7% | $190.5M | $196.8M | +3.3% |
| 8/8/2024 | $-1.00 | $-1.16 | -16.0% | $185.3M | $186.7M | +0.7% |
| 4/25/2024 | $-1.21 | $-1.20 | +0.8% | $170.4M | $210.1M | +23.3% |
| 2/29/2024 | $0.29 | $-0.24 | -182.8% | $321.3M | $307.1M | -4.4% |
| 10/26/2023 | $-0.85 | $-1.76 | -107.1% | $210.2M | $196.6M | -6.5% |
| 8/3/2023 | $-1.58 | $-2.66 | -68.4% | $207.0M | $213.8M | +3.3% |
| 4/27/2023 | $-1.64 | $-1.88 | -14.6% | $204.5M | $220.4M | +7.8% |
| 2/21/2023 | $-1.96 | $-2.35 | -19.9% | $188.4M | $167.4M | -11.1% |
| 10/27/2022 | $-1.37 | $-1.53 | -11.7% | $178.5M | $217.1M | +21.6% |
| 8/4/2022 | $-1.67 | $-2.13 | -27.5% | $162.1M | $165.5M | +2.1% |
| 5/3/2022 | $-1.55 | $-1.78 | -14.8% | $146.9M | $148.7M | +1.2% |
| 2/22/2022 | $-1.79 | $-2.03 | -13.4% | $150.8M | $165.2M | +9.5% |
| 10/28/2021 | $-1.78 | $-1.89 | -6.2% | $126.4M | $138.7M | +9.7% |
| 7/29/2021 | $-1.84 | $-1.68 | +8.7% | $116.7M | $116.7M | 0.0% |
| 5/4/2021 | $-1.59 | $-1.83 | -15.1% | $95.8M | $117.9M | +23.2% |
| 2/25/2021 | $-0.90 | $-1.08 | -20.0% | $111.4M | $118.9M | +6.7% |
| 10/29/2020 | $-1.10 | $-1.03 | +6.4% | $6.9M | $118.4M | +1616.7% |
| 8/5/2020 | $-1.29 | $-2.65 | -105.4% | $58.0M | $75.2M | +29.7% |
| 4/30/2020 | $-1.16 | $-1.80 | -55.2% | $50.2M | $68.3M | +36.1% |
| 3/2/2020 | $-0.53 | $-1.15 | -117.0% | $25.4M | $96.5M | +279.6% |
| 10/29/2019 | $-0.91 | $-0.89 | +2.2% | $51.2M | $71.4M | +39.5% |
| 8/6/2019 | $-0.46 | $-0.66 | -43.5% | $66.1M | $85.5M | +29.3% |
| 5/2/2019 | $-0.74 | $-0.91 | -23.0% | $40.1M | $53.6M | +33.5% |
| 2/28/2019 | $-0.43 | $-0.46 | -7.0% | $28.8M | $86.3M | +200.0% |
| 11/5/2018 | $-0.40 | $-0.94 | -135.0% | $20.2M | $53.6M | +165.0% |
| 8/7/2018 | $-0.36 | $-0.09 | +75.0% | $94.9M | $68.7M | -27.6% |
| 5/9/2018 | $-0.49 | $-0.46 | +6.1% | $52.4M | $56.1M | +7.0% |
| 3/6/2018 | $-0.14 | $0.03 | +121.4% | $364.1M | $78.0M | -78.6% |
| 11/2/2017 | $-0.66 | $-0.67 | -1.5% | $34.7M | $41.9M | +20.6% |
| 8/8/2017 | $-0.89 | $-0.44 | +50.6% | $139.5M | $48.0M | -65.6% |
| 5/8/2017 | $-0.88 | $-0.85 | +3.4% | $32.2M | $26.5M | -17.5% |
| 3/16/2017 | $-0.99 | $-0.78 | +21.2% | $34.6M | $25.2M | -27.1% |
| 11/2/2016 | $-1.21 | $-1.03 | +14.9% | $27.2M | $23.0M | -15.6% |
| 8/4/2016 | $-1.28 | $-1.14 | +10.9% | $17.4M | $15.6M | -10.2% |
| 5/5/2016 | $-1.21 | $-1.16 | +4.1% | $19.5M | $18.9M | -3.2% |
| 2/29/2016 | $-1.27 | $-1.50 | -18.1% | $10.5M | $12.7M | +21.0% |
| 11/9/2015 | $-1.12 | $-1.27 | -13.4% | $8.9M | $9.8M | +10.4% |
| 7/30/2015 | $-1.20 | $-1.14 | +5.0% | $7.1M | $6.4M | -10.7% |
| 5/4/2015 | $-1.31 | $-1.15 | +12.2% | $7.8M | $5.4M | -30.7% |
| 2/27/2015 | $-0.83 | $-0.84 | -1.2% | $12.4M | $11.6M | -6.1% |
| 11/6/2014 | $-0.91 | $-0.93 | -2.2% | $1.6M | $797,000 | -51.4% |
| 8/7/2014 | $-0.74 | $-0.86 | -16.2% | $1.4M | $1.4M | -1.7% |
| 5/6/2014 | $-0.44 | $-0.58 | -31.8% | $7.3M | $9.1M | +25.1% |
| 3/6/2014 | $-0.58 | $-0.75 | -29.3% | $3.4M | $3.9M | +17.3% |
| 11/14/2013 | $-0.29 | $-0.19 | +34.5% | $25.7M | $15.5M | -39.9% |
| 8/13/2013 | — | $-0.61 | — | — | $5.9M | — |
| 12/31/2012 | — | $-0.26 | — | — | $5.9M | — |
| 9/30/2012 | — | $-0.31 | — | — | $6.0M | — |
| 6/30/2012 | — | $-0.26 | — | — | $6.1M | — |
| 3/31/2012 | — | $-0.28 | — | — | $10.8M | — |
Need PTCT data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.